Results 31 to 40 of about 5,149,759 (252)

Lipoprotein(a) and Its Autoantibodies in Association with Calcific Aortic Valve Stenosis

Diseases, 2023
Aortic valve stenosis is the most common valvular heart disease in the Western world. Lipoprotein(a) (Lp(a)) is an independent risk factor of coronary heart disease (CHD) and calcific aortic valve stenosis (CAVS).
Anna L. Burdeynaya, Olga I. Afanasieva, Marat V. Ezhov, Elena A. Klesareva, Marina A. Saidova, Sergey N. Pokrovsky   +5 more
doaj   +1 more source

Transcatheter Aortic Valve Implantation in Dialysis Patients [PDF]

, 2012
Background/Aims: Transcatheter aortic valve implantation (TAVI) has emerged as a new therapeutic option for high-risk patients. However, dialysis patients were excluded from all previous studies.
Wessely, Matthias, Schoenermarck, Ulf, Rau, Simon, Fischereder, Michael, Steinbeck, Gerhard, Kupatt, Christian, Lange, Philipp   +6 more
core   +1 more source

Post-stenotic aortic dilatation. [PDF]

, 2006
Aortic stenosis is the most common valvular heart disease affecting up to 4% of the elderly population. It can be associated with dilatation of the ascending aorta and subsequent dissection.
Jahangiri Marjan, Marjan Jahangiri, Wilton, E, Emma Wilton, Jahangiri, M, Wilton Emma   +5 more
core   +2 more sources

SENILE CALCIFIC AORTIC VALVE STENOSIS: MODERN INTERVENTIONS IN UKRAINE

Anti-Aging Eastern Europe, 2022
Background. Aortic valve stenosis remains the most dominant form of valvular heart disease. The aortic valve area below 1.0 cm2 is an assignment to the interventions.
Uliana Pidvalna, Dmytro Beshley
doaj   +1 more source

Interdisciplinary three-step strategy to treat aortic stenosis and coronary artery disease in a patient with end-stage chronic obstructive pulmonary disease [PDF]

, 2012
Background: Valvular aortic stenosis is a common disease in the elderly, often in multimorbid patients. It is often associated with coronary artery disease and peripheral artery disease.
Michel, Sebastian, Schmitz, Christoph, Kaczmarek, Ingo, Sodian, Ralf, Wolf, Manuel, Bigdeli, Amir Khosrow, Beiras Fernández, Andrés   +6 more
core   +1 more source

High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis [PDF]

, 2014
AIMS: High-sensitivity cardiac troponin I (cTnI) assays hold promise in detecting the transition from hypertrophy to heart failure in aortic stenosis.
Lang, Chim C., Langrish, Jeremy P, Langrish, Jeremy P., Newby, David E., Shah, Anoop, Dweck, Marc R, Alam, Shirjel, Mills, Nicholas L; id_orcid, McAllister, David A, Hunter, Amanda L., Cowell, S. Joanna, Boon, Nicholas A, Shah, Anoop S.V., Strachan, Fiona E, McAllister, David A., Maria Choy, Anna; id_orcid, Strachan, Fiona E., Boon, Nicholas A., Mills, Nicholas L., Dweck, Marc R., Shah, Anoop S. V., Newby, David E, Lang, Chim C.; id_orcid, Chin, Calvin W.L., Chin, Calvin W L, Chin, Calvin W. L., Joanna Cowell, S, Maria Choy, Anna, Walker, Simon, Lang, Chim C, Hunter, Amanda L   +30 more
core   +1 more source

A Coupled Multiscale Approach to Modeling Aortic Valve Mechanics in Health and Disease

Applied Sciences, 2021
Mechano-biological processes in the aortic valve span multiple length scales ranging from the molecular and cell to tissue and organ levels. The valvular interstitial cells residing within the valve cusps sense and actively respond to leaflet tissue ...
Ahmed A. Bakhaty, Sanjay Govindjee, Mohammad R. K. Mofrad   +2 more
doaj   +1 more source

Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. [PDF]

, 2012
BACKGROUND: Transcatheter aortic-valve replacement (TAVR) is the recommended therapy for patients with severe aortic stenosis who are not suitable candidates for surgery. The outcomes beyond 1 year in such patients are not known.
Makkar, Raj R, Dewey, Todd M, Pocock, Stuart, Brown, David L, Pichard, Augusto D, Bowers, Bruce, Siegel, Robert J, Smith, Craig R, Webb, John G, Tuzcu, Murat, Moses, Jeffrey W, Williams, Matthew R, Babaliaros, Vasilis C, Thourani, Vinod H, Kapadia, Samir, Svensson, Lars G, Jilaihawi, Hasan, Kodali, Susheel, Bavaria, Joseph E, MD, Fontana, Gregory P, Akin, Jodi J, Douglas, Pamela S, Bavaria, Joseph E, Herrmann, Howard C, Leon, Martin B, PARTNER Trial Investigators, Anderson, William N   +26 more
core   +1 more source

Animal Models of Calcific Aortic Valve Disease [PDF]

International Journal of Inflammation, 2011
Calcific aortic valve disease (CAVD), once thought to be a degenerative disease, is now recognized to be an active pathobiological process, with chronic inflammation emerging as a predominant, and possibly driving, factor. However, many details of the pathobiological mechanisms of CAVD remain to be described, and new approaches to treat CAVD need to be
Sider, Krista L., Blaser, Mark C., Simmons, Craig A.   +2 more
openaire   +4 more sources

Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study. [PDF]

, 2014
OBJECTIVE: To use patient-level data from the ADVANCE study to evaluate the cost-effectiveness of transcatheter aortic valve implantation (TAVI) compared to medical management (MM) in patients with severe aortic stenosis from the perspective of the UK ...
Busca, R, Axel Linke, Amie Padhiar, Peter Wenaweser, Neil Moat, Piazza, N, Stuart Mealing, Johan Bosmans, Mealing, S, Stephen Brecker, Mark Sculpher, Ulrich J Gerckens, Nicolo Piazza, Rachele Busca, Padhiar, A, Sabine Bleiziffer, Tamburino, C, Sculpher, M, Bosmans, J, Gerckens, UJ, Bleiziffer, S, Linke, A, James Eaton, Eaton, J, Wenaweser, P, Moat, N, Corrado Tamburino, Brecker, S, Brecker, Stephen, Mealing, Stuart, Padhiar, Arnie, et al., Bosmans, Johan   +32 more
core   +1 more source